144 related articles for article (PubMed ID: 36533709)
21.
Liu SP; Li XM; Liu DM; Xie SH; Zhang SB; Li Y; Xie ZF
Front Oncol; 2022; 12():884448. PubMed ID: 35530327
[TBL] [Abstract][Full Text] [Related]
22. Identification of potential biomarkers associated with immune infiltration in the esophageal carcinoma tumor microenvironment.
Wang Z; Chen M; Qiu Y; Yang Y; Huang Y; Li X; Zhang W
Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33543230
[TBL] [Abstract][Full Text] [Related]
23. Highly Expressed Z-DNA Binding Protein 1 in Esophageal Cancer Promotes Tumor Growth.
Wusiman S; Liu Y; Li H; Deng Y; Qu X; Tuerxun H; Liu L
Dig Dis Sci; 2024 May; 69(5):1674-1690. PubMed ID: 38507125
[TBL] [Abstract][Full Text] [Related]
24. High expression of HNRNPR in ESCA combined with
Liu XY; Gao Y; Kui XY; Liu XS; Zhang YH; Zhang Y; Ke CB; Pei ZJ
J Transl Med; 2022 Oct; 20(1):450. PubMed ID: 36195940
[TBL] [Abstract][Full Text] [Related]
25. Screening and verification of potential gene targets in esophageal carcinoma by bioinformatics analysis and immunohistochemistry.
Wen P; Dayyani F; Tao R; Zhong X
Ann Transl Med; 2022 Jan; 10(2):70. PubMed ID: 35282073
[TBL] [Abstract][Full Text] [Related]
26. Identification and validation of UBE2B as a prognostic biomarker promoting the development of esophageal carcinomas.
Ding H; Xu JC; Ding ZG; Wu LF; Liu YB; Zhang YF; Chen TY; Zhang YQ; Zhou PH
Front Immunol; 2024; 15():1295305. PubMed ID: 38481990
[TBL] [Abstract][Full Text] [Related]
27. Decreased APOC1 expression inhibited cancer progression and was associated with better prognosis and immune microenvironment in esophageal cancer.
Guo Q; Liu XL; Jiang N; Zhang WJ; Guo SW; Yang H; Ji YM; Zhou J; Guo JL; Zhang J; Liu HS
Am J Cancer Res; 2022; 12(11):4904-4929. PubMed ID: 36504892
[TBL] [Abstract][Full Text] [Related]
28. CDKL3 shapes immunosuppressive tumor microenvironment and initiates autophagy in esophageal cancer.
Bi Y; Liu J; Qin S; Ji F; Zhou C; Yang H; Zhou S
Front Immunol; 2024; 15():1295011. PubMed ID: 38562942
[TBL] [Abstract][Full Text] [Related]
29. Identification of crucial genes correlated with esophageal cancer by integrated high-throughput data analysis.
Zhou W; Wu J; Liu X; Ni M; Meng Z; Liu S; Jia S; Zhang J; Guo S; Zhang X
Medicine (Baltimore); 2020 May; 99(20):e20340. PubMed ID: 32443386
[TBL] [Abstract][Full Text] [Related]
30. A Novel Three-miRNA Signature Identified Using Bioinformatics Predicts Survival in Esophageal Carcinoma.
Wu K; Zhang C; Zhang C; Dai D
Biomed Res Int; 2020; 2020():5973082. PubMed ID: 32104700
[TBL] [Abstract][Full Text] [Related]
31. eIF6 is potential diagnostic and prognostic biomarker that associated with
Gao Y; Yuan L; Zeng J; Li F; Li X; Tan F; Liu X; Wan H; Kui X; Liu X; Ke C; Pei Z
J Transl Med; 2022 Jul; 20(1):303. PubMed ID: 35794622
[TBL] [Abstract][Full Text] [Related]
32. Metabolic subtypes and immune landscapes in esophageal squamous cell carcinoma: prognostic implications and potential for personalized therapies.
Yu XW; She PW; Chen FC; Chen YY; Zhou S; Wang XM; Lin XR; Liu QL; Huang ZJ; Qiu Y
BMC Cancer; 2024 Feb; 24(1):230. PubMed ID: 38373930
[TBL] [Abstract][Full Text] [Related]
33. Identification of Autophagy-Related Genes and Small-Molecule Drugs in Esophageal Carcinoma.
Li Z; Dong K; Guo P; Tan Z; Zhang F; Tian Y; Lv H
Med Sci Monit; 2020 May; 26():e921855. PubMed ID: 32415055
[TBL] [Abstract][Full Text] [Related]
34. Knockdown of NOLC1 Inhibits PI3K-AKT Pathway to Improve the Poor Prognosis of Esophageal Carcinoma.
Kong F; Shang Y; Diao X; Huang J; Liu H
J Oncol; 2021; 2021():9944132. PubMed ID: 34046062
[TBL] [Abstract][Full Text] [Related]
35. Glycerol kinase enzyme is a prognostic predictor in esophageal carcinoma and is associated with immune cell infiltration.
Ying F; Chen X; Lv L
Sci Rep; 2024 Feb; 14(1):3922. PubMed ID: 38365953
[TBL] [Abstract][Full Text] [Related]
36. LncRNA AC007255.1, an immune-related prognostic enhancer RNA in esophageal cancer.
Wang Q; Yu X; Yang N; Xu L; Zhou Y
PeerJ; 2021; 9():e11698. PubMed ID: 34316393
[TBL] [Abstract][Full Text] [Related]
37. COX7B Is a New Prognostic Biomarker and Correlates with Tumor Immunity in Esophageal Carcinoma.
Song Y; Gao N; Yang Z; Zhang S; Fan T; Zhang B
Mediators Inflamm; 2023; 2023():6831695. PubMed ID: 37273454
[TBL] [Abstract][Full Text] [Related]
38. CASP4 and CASP8 as newly defined autophagy-pyroptosis-related genes associated with clinical and prognostic features of renal cell carcinoma.
Li T; Liu N; Zhang G; Chen M
J Cancer Res Ther; 2022 Dec; 18(7):1952-1960. PubMed ID: 36647955
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of CENPL mRNA potentially regulated by miR-340-3p predicts the prognosis of pancreatic cancer patients.
Cui Z; Du L; Wang J; Li Z; Xu J; Ou S; Li D; Li S; Hu H; Chen G; Wu Z
BMC Cancer; 2022 Dec; 22(1):1354. PubMed ID: 36572856
[TBL] [Abstract][Full Text] [Related]
40. Identification and validation of DPY30 as a prognostic biomarker and tumor immune microenvironment infiltration characterization in esophageal cancer.
Mei PY; Xiao H; Guo Q; Meng WY; Wang ML; Huang QF; Liao YD
Oncol Lett; 2023 Feb; 25(2):68. PubMed ID: 36644145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
